Enlightenment Research’s Exelixis EXEL Stock Holding History

Enlightenment Research’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-23,000	Closed	-$452K	–	159
2019 Q2	$452K	Buy	+23,000	New	+$482K	0.23%	128

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Enlightenment Research's EXEL Position: Q3 2019 in Review

Enlightenment Research sold out of Exelixis (EXEL) in Q3 2019, closing a stake of 23,000 shares — an estimated $452K sold.

Enlightenment Research first reported a position in EXEL in Q2 2019 and held it in 1 quarter. The position peaked at $452K in Q2 2019. 339 funds tracked by Wall St. Rank hold EXEL as of Q3 2019.

Enlightenment Research reported no remaining Exelixis position as of Q3 2019 after selling out during the quarter.
Enlightenment Research sold 23,000 Exelixis shares in Q3 2019, an estimated $452K.
Enlightenment Research first reported a position in Exelixis in Q2 2019 and held it in 1 quarter.
Enlightenment Research's Exelixis position peaked at $452K in Q2 2019.
339 funds tracked by Wall St. Rank held Exelixis as of Q3 2019.

Based on Enlightenment Research's 13F filing for Q3 2019, filed 16 Oct 2019.